Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | HPGD | P15428 | 5/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | KIF11 | P52732 | 2/20 | 0.46 |
| ▸ | CTSV | O60911 | 1/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | GABRP | O00591 | 3/20 | 0.43 |
| ▸ | GABRD | O14764 | 3/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6428202 | 0.99 | MAPT (0.52) | MAPTMAPK1NPSR1KDM4EHSD17B10 | |
| SCHEMBL23803147 | 0.99 | MAPT (0.52) | MAPTMAPK1NPSR1KDM4EHSD17B10 | |
| SCHEMBL4330629 | 0.95 | MAPK1 (0.55) | MAPTMAPK1NPSR1KDM4EHSD17B10 | |
| SCHEMBL29025958 | 0.92 | KDM4E (0.48) | MAPTMAPK1NPSR1KDM4EHSD17B10 | |
| SCHEMBL27985630 | 0.92 | KDM4E (0.48) | MAPTMAPK1NPSR1KDM4EHSD17B10 | |
| SCHEMBL2548395 | 0.92 | HSD17B10 (0.54) | MAPTMAPK1NPSR1KDM4EHSD17B10 | |
| SCHEMBL28767664 | 0.90 | KDM4E (0.53) | MAPTMAPK1NPSR1KDM4EHSD17B10 | |
| SCHEMBL27912728 | 0.88 | MAPK1 (0.50) | MAPTMAPK1NPSR1KDM4EHSD17B10 | |
| SCHEMBL28153486 | 0.86 | MAPT (0.54) | MAPTMAPK1NPSR1KDM4EHSD17B10 | |
| SCHEMBL28020635 | 0.85 | MAPT (0.50) | MAPTMAPK1NPSR1KDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112110847-A | Novel diarylacylcarbazole compound and application thereof as sensitizer | 江苏英力科技发展有限公司 | 2020-12-22 | — | — | CN | claimed |
| US-11937495-B2 | Organic light emitting element, composition and membrane | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2024-03-19 | — | — | US | disclosed |
| EP-3843168-B1 | ORGANIC LIGHT EMITTING ELEMENT, COMPOSITION AND MEMBRANE | UNIV KYUSHU NAT UNIV CORP (JP) | 2023-10-11 | — | — | EP | disclosed |
| CN-113518774-A | Novel diarylacylcarbazole compound and application thereof as sensitizer | 艾坚蒙(安庆)科技发展有限公司 | 2021-10-19 | — | — | CN | disclosed |
| EP-3843168-A1 | ORGANIC LIGHT EMITTING ELEMENT, COMPOSITION AND MEMBRANE | Kyushu University, National University Corporation (JP) | 2021-06-30 | — | — | EP | disclosed |
| CN-112585778-A | Organic light-emitting element, composition, and film | 国立大学法人九州大学 | 2021-03-30 | — | — | CN | disclosed |
| CN-112110848-A | Novel diarylacylcarbazole compound and application thereof as sensitizer | 江苏英力科技发展有限公司 | 2020-12-22 | — | — | CN | disclosed |
| CN-112110847-A | Novel diarylacylcarbazole compound and application thereof as sensitizer | 江苏英力科技发展有限公司 | 2020-12-22 | — | — | CN | disclosed |
| WO-2020039930-A1 | ORGANIC LIGHT EMITTING ELEMENT, COMPOSITION AND MEMBRANE | 国立大学法人九州大学 | 2020-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11937495-B2 | Organic light emitting element, composition and membrane | CRY1, INTS9, CYBA | MAPT 3556/4885MAPK1 2913/4885NPSR1 4460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.